Silverfin false false 31/12/2024 21/09/2023 31/12/2024 J Kohles 05/12/2023 D Lobban 05/12/2023 D C Thompson 16/04/2024 A C Wadsworth 21/09/2023 10 June 2025 no description of principal activity 15152487 2024-12-31 15152487 bus:Director1 2024-12-31 15152487 bus:Director2 2024-12-31 15152487 bus:Director3 2024-12-31 15152487 bus:Director4 2024-12-31 15152487 core:CurrentFinancialInstruments 2024-12-31 15152487 core:ShareCapital 2024-12-31 15152487 core:SharePremium 2024-12-31 15152487 core:AdditionsToInvestments 2024-12-31 15152487 core:CostValuation 2024-12-31 15152487 bus:OrdinaryShareClass1 2024-12-31 15152487 bus:OrdinaryShareClass2 2024-12-31 15152487 bus:OrdinaryShareClass3 2024-12-31 15152487 bus:OrdinaryShareClass4 2024-12-31 15152487 2023-09-21 2024-12-31 15152487 bus:FilletedAccounts 2023-09-21 2024-12-31 15152487 bus:SmallEntities 2023-09-21 2024-12-31 15152487 bus:AuditExemptWithAccountantsReport 2023-09-21 2024-12-31 15152487 bus:PrivateLimitedCompanyLtd 2023-09-21 2024-12-31 15152487 bus:Director1 2023-09-21 2024-12-31 15152487 bus:Director2 2023-09-21 2024-12-31 15152487 bus:Director3 2023-09-21 2024-12-31 15152487 bus:Director4 2023-09-21 2024-12-31 15152487 bus:OrdinaryShareClass1 2023-09-21 2024-12-31 15152487 bus:OrdinaryShareClass2 2023-09-21 2024-12-31 15152487 bus:OrdinaryShareClass3 2023-09-21 2024-12-31 15152487 bus:OrdinaryShareClass4 2023-09-21 2024-12-31 iso4217:GBP xbrli:pure xbrli:shares

Company No: 15152487 (England and Wales)

AMICA SCIENTIFIC (HOLDINGS) LIMITED

Unaudited Financial Statements
For the financial period from 21 September 2023 to 31 December 2024
Pages for filing with the registrar

AMICA SCIENTIFIC (HOLDINGS) LIMITED

Unaudited Financial Statements

For the financial period from 21 September 2023 to 31 December 2024

Contents

AMICA SCIENTIFIC (HOLDINGS) LIMITED

BALANCE SHEET

As at 31 December 2024
AMICA SCIENTIFIC (HOLDINGS) LIMITED

BALANCE SHEET (continued)

As at 31 December 2024
Note 31.12.2024
£
Fixed assets
Investments 3 100
100
Current assets
Debtors 4 399,188
399,188
Net current assets 399,188
Total assets less current liabilities 399,288
Net assets 399,288
Capital and reserves
Called-up share capital 5 100
Share premium account 399,188
Total shareholders' funds 399,288

For the financial period ending 31 December 2024 the Company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.

Directors' responsibilities:

The financial statements of Amica Scientific (Holdings) Limited (registered number: 15152487) were approved and authorised for issue by the Board of Directors on 10 June 2025. They were signed on its behalf by:

A C Wadsworth
Director
AMICA SCIENTIFIC (HOLDINGS) LIMITED

NOTES TO THE FINANCIAL STATEMENTS

For the financial period from 21 September 2023 to 31 December 2024
AMICA SCIENTIFIC (HOLDINGS) LIMITED

NOTES TO THE FINANCIAL STATEMENTS

For the financial period from 21 September 2023 to 31 December 2024
1. Accounting policies

The principal accounting policies are summarised below. They have all been applied consistently throughout the financial period, unless otherwise stated.

General information and basis of accounting

Amica Scientific (Holdings) Limited (the Company) is a private company, limited by shares, incorporated in the United Kingdom under the Companies Act 2006 and is registered in England and Wales. The address of the Company's registered office is Turner Heath, 103 Bollington Road, Bollington, SK10 5EL, United Kingdom.

The financial statements have been prepared under the historical cost convention, modified to include certain items at fair value, and in accordance with Section 1A of Financial Reporting Standard 102 (FRS 102) ‘The Financial Reporting Standard applicable in the UK and Republic of Ireland’ issued by the Financial Reporting Council and the requirements of the Companies Act 2006 as applicable to companies subject to the small companies regime.

The financial statements are presented in pounds sterling which is the functional currency of the Company and rounded to the nearest £.

Impairment of assets

Assets, other than those measured at fair value, are assessed for indicators of impairment at each Balance Sheet date. If there is objective evidence of impairment, an impairment loss is recognised in the Statement of Income and Retained Earnings as described below.

Trade and other debtors

Trade and other debtors are initially recognised at fair value and thereafter stated at amortised cost using the effective interest method less impairment losses for bad and doubtful debts, except where the effect of discounting would be immaterial. In such cases the receivables are stated at cost less impairment losses for bad and doubtful debts.

Trade and other creditors

Trade and other creditors are initially recognised at fair value and thereafter stated at amortised cost using the effective interest rate method, unless the effect of discounting would be immaterial, in which case they are stated at cost.

Financial instruments

The company only enters into basic financial instrument transactions that result in the recognition of financial assets and liabilities like trade and other debtors and creditors, loans from banks and other third parties, loans to related parties and investment in non-puttable ordinary shares.

Valuation of investments

Investments in subsidiaries are measured at cost less accumulated impairment

2. Employees

Period from
21.09.2023 to
31.12.2024
Number
Monthly average number of persons employed by the Company during the period. 0

The directors did not receive any remuneration in the period.

3. Fixed asset investments

Investments in subsidiaries

31.12.2024
£
Cost
At 21 September 2023 0
Additions 100
At 31 December 2024 100
Carrying value at 31 December 2024 100

4. Debtors

31.12.2024
£
Amounts owed by Group undertakings 399,138
Other debtors 50
399,188

5. Called-up share capital

31.12.2024
£
Allotted, called-up and fully-paid
25 A Ordinary shares of £ 1.00 each 25
25 B Ordinary shares of £ 1.00 each 25
25 C Ordinary shares of £ 1.00 each 25
25 D Ordinary shares of £ 1.00 each 25
100

Upon incorporation, the company issued 1 Ordinary share at £1, which was later reclassified to an A Ordinary share on 5 December 2023.

On 5 December 2023, the company issued 24 A Ordinary shares at £1 each, 25 B Ordinary shares at £1 each and 25 C Ordinary shares at a premium.

On 16 April 2024, the company issued 25 D Ordinary shares at a premium.